We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Redx Pharma Plc | LSE:REDX | London | Ordinary Share | GB00BSNB6S51 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -10.00% | 9.00 | 8.00 | 10.00 | 9.00 | 9.00 | 9.00 | 10,857 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.2M | -33.16M | -0.0852 | -1.17 | 38.9M |
TIDMREDX
RNS Number : 7880Y
Redx Pharma plc
07 March 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or Redx Pharma Plc the underlying issuer of existing shares to which voting rights are attached: (ii) ----------------------------------------------------------- ------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------ ------------------------------ An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------ ------------------------------ An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------ ------------------------------ An event changing the breakdown of voting rights ------------------------------------------------------------ ------------------------------ Other (please specify): ---------------------------------------------------------- ------------------------------ 3. Full name of person(s) Seneca Partners Limited subject to the notification obligation: (iii) ----------------------------------------------------------- ------------------------------- 4. Full name of shareholder(s) Acceleris Nominees Limited (if different from 3.):(iv) Share Nominees Limited WCS Nominees Limited Platform Securities Nominees Limited ----------------------------------------------------------- ------------------------------- 5. Date of the transaction 28.02.2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ------------------------------- 6. Date on which issuer 07.03.2017 notified: ----------------------------------------------------------- ------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 12% ----------------------------------------------------------- ------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE ------------- -------------------------------- --------------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights ------------- --------------- --------------- ------------- --------------------------- ------------------------- Direct Direct Indirect Direct Indirect (xi) (xii) ------------- ----------- ----------- ------------- ------------- ------------ ------------ ----------- Ordinary shares of GBP0.01 each 10,707,781 10,707,781 12.49% --------------- --------------- ------------ ------------ ----------- GB00BSNB6S51 15,792,781 15,792,781 ------------- ----------- ----------- ------------- ------------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. ----------------- ------------- ------------------------------ ----------------------------- --------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) --------------- ------------- ------------- --------------- ----------------------------- ----------------------- Nominal Delta --------------- ------------- ------------- --------------- ----------------------------- ------------ --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------- ------------------------------------------------------------------- 15,792,781 12.49% ------------------------------------------------- ------------------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) -------------------------------------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ----------------------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ----------------------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ----------------------------- Number based on reported 13. Additional information: 126,477,914 shares in issue as per RNS issued by the Company on 28.02.2017. ------------------------------------------------------------- ----------------------------- 14. Contact name: Anthony Lappin ------------------------------------------------------------- ----------------------------- 15. Contact telephone number: 01942 271 746 ------------------------------------------------------------- -----------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBLGDXGXGBGRR
(END) Dow Jones Newswires
March 07, 2017 11:33 ET (16:33 GMT)
1 Year Redx Pharma Chart |
1 Month Redx Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions